The Barnabas Health Heart Center at Newark Beth Israel Medical Center, New Jersey’s most comprehensive cardiac program, was recently recognized for excellence in multiple national cardiac health rankings.
The American Heart Association (AHA) awarded the Heart Center at Newark Beth Israel Medical Center its 2012 Get With the Guidelines Gold Award for Heart Failure for the third consecutive year. This prestigious award is presented to hospitals that follow the latest evidence-based treatment guidelines for heart failure as outlined by the AHA/American College of Cardiology.
Heart disease is the leading cause of hospitalization in the U.S. and it is estimated that nearly 6 million Americans have heart failure. There is no cure for heart failure, but with early diagnosis and aggressive treatment, symptoms can be controlled. AHA’s Get With The Guidelines program is a quality improvement initiative that outlines the best treatment practices to help people better manage their disease, improve their quality of life and avoid costly hospitalization.
Newark Beth Israel also earned the AHA’s Mission: Lifeline Silver Quality Achievement Award for its success in implementing a higher standard of care that improves the survival of people who suffer a certain kind of heart attack.
An ST-elevation myocardial infarction (STEMI), the most common type of heart attack, occurs when an artery that supplies blood to the heart is suddenly blocked. The sooner the blockage is removed, the better the heart muscle will recover with fewer complications. Mission: Lifeline focuses on improving the system of care for people that suffer STEMI, a well as other kinds of heart attacks.
Hospitals across the nation participating in the Mission: Lifeline initiative are improving care in the acute treatment phase and at hospital discharge. In addition to re-establishing blood flow through the blocked artery within specific time frames, patients are started on aggressive risk reduction therapies such as cholesterol lowering medications, aspirin, ACE inhibitors and beta blockers in the hospital and receive smoking cessation counseling. Newark Beth Israel’s Heart Center and Emergency Department teams continually review and refine the way care is provided in cardiovascular emergencies. It was one of the first hospitals in New Jersey to admit STEMI patients directly to the Catheterization Lab for angioplasty procedures that open blocked coronary arteries and prevent cardiac complications.
Newark Beth Israel Medical Center is home to the third largest heart transplant program in the U.S., performing more than 700 transplants since the program began in 1989. According to the Scientific Registry of Transplant Recipients, which maintains the national database of transplant statistics and supports the scientific and clinical evaluation of organ transplantation, Newark Beth Israel has consistently achieved patient survival rates that exceed or meet national benchmarks. In addition to exceptional patient care, the Heart Failure Treatment and Transplant Program is at the forefront of clinical research and offers the benefits of the latest generation of ventricular assist devices, a revolutionary donor organ preservation system and breakthrough therapies.
The recent designation by U.S. News & World Report as one of the Best Hospitals in New Jersey and the New York metro area, as well as High Performing in Cardiology and Heart Surgery, is evidence of the highest standard of care delivered every day at the Barnabas Health Heart Center at Newark Beth Israel Medical Center.
“Achieving sustained success across the continuum of cardiac care is all about team work,” said John A. Brennan, MD, MPH, Chief Executive Officer of Newark Beth Israel Medical Center and Children’s Hospital of New Jersey. “We are proud to be aligned with the American Heart Association and remain committed to enhancing the lives of our patients through quality care and a broad spectrum of cardiac research.
About the Barnabas Heart Center at Newark Beth Israel Medical Center
Newark Beth Israel Medical Center, NJ, has a distinguished history in the field of cardiology. Its pioneering physicians performed the first early coronary bypass procedures as well as the first heart transplant in New Jersey. Their work in the development and use of pacemakers is world renowned. Building on that legacy, Newark Beth’s nationally respected cardiac physicians, surgeons and researchers continue to make significant advances in cardiac care.
At Newark Beth Israel Medical Center, New Jersey residents have access to one of the nation’s finest and most comprehensive cardiac programs for adults and children. Highly specialized care includes minimally invasive and robotic-assisted cardiac surgery, Valve and Atrial Fibrillation Centers, state-of-the-art imaging technology for more precise diagnosis, highly specialized care for children and adults with congenital heart disease, and heart transplantation.
Date: August 21, 2012
Contact: Caren Malone
Public Relations Department
top ] [ back to News Index ]